About
GENERAL INFORMATION
Sakarya Medical Journal is a peer-reviewed scientific journal that aims to reach all national and international medical institutions and personnel, publishing retrospective, prospective or experimental research, review, case report, editorial comment/discussion, letter to the editor and current issues that determine the medical agenda, which may be related to every branch of medicine. is a magazine. Web of Science Category has been determined as 'General and Internal Medicine'. It is indexed by DOAJ, TR Index and EBSCO (Central Eastern European Academic Source).. All manuscripts are subject to double-blind peer review. For this reason, the main text file to be sent to the referees should not include the names of any authors or institutions. All manuscripts must be original, scientific, not previously published in another medium or sent to another journal for publication. All manuscripts must be checked for plagiarism, and ethics committee approval must be obtained for studies using humans and animals. The journal is published four times a year in March, June, September and December. The official publication languages of the journal are Turkish and English. English writing is preferred. Turkish articles should have an English abstract, and English articles should have a Turkish abstract. Research articles are prioritized, and limited number of articles with sufficient priority are accepted for case presentation. LCC category is W.
All kinds of transactions and applications related to the journal can be made at https://dergipark.org.tr/smj. Application methods other than the Dergipark system are not accepted. NOTE: Please read the spelling rules before uploading your works.
The average time during which the preliminary assessment of manuscripts is conducted: 15 days.
The average time during which the reviews of manuscripts are conducted: 60 days.
The average time in which the article is published: 90 days.
The published articles in SMJ are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.